Table 3.
Comparative analysis of top 10 features in osteoporosis prediction studies
| Non-RA | RA | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Ranking | Erjiang et al. [26] | Park et al. [27] | Bui et al. [28] | Shodikulova et al. [29] | Hu et al. [30] | Yan et al. [20] | Chen et al. [21] | Lee et al. [22] | Our study |
| 1 | Age | Age | Age | Joint Activity | Age | Age | Serum Selenium | Body mass index | Weight |
| 2 | Weight | Menopause | Weight | Immunologic Variants | Body Mass Index | Disease Course | Bone Mineral Density | Age | Vitamin D Supplements |
| 3 | Bisphosphonate use | Alkaline phosphatase | Height | Age | Serum 25-hydroxyvitamin D3 Level | DAS28 | Rheumatoid Factor | Menopause | Alendronate Sodium |
| 4 | Body Mass Index | Weight | Uric acid | Glucocorticoids | Tumor Necrosis Factor Inhibitor Usage | Anti-Cyclic Citrullinated Peptide Antibody | High-sensitivity C-Reactive Protein | Waist circumference | Daily physical activity level |
| 5 | Denosumab use | Forced vital capacity | Calcium | Hypocalcemia | Serum Uric Acid Level | 7-Joint Ultrasonic Bone Erosion | Erythrocyte Sedimentation Rate | Hip circumference | Height |
| 6 | Estrogen use | Sobriety | Cholesterol | Family History of Bone Fractures | Disease Duration | / | History of Long-term Glucocorticoid Use | Surgery for RA | Age |
| 7 |
Chronic Respiratory Disease |
Aspartate aminotransferase |
Creatinine | Menopause | / | / | RA Duration | Monthly income | Golimumab |
| 8 | Osteopenia | Diastolic blood pressure | Free thyroxine level | Back Pain and Joint Deformation | / | / | Family History of Osteoporosis | Age of diagnosis | Synovitis in Both Knees |
| 9 | Height loss | Riboflavin intake | Glucose | Physical Activity and Nutrition | / | / | Smoking History | Health assessment questionnaire | Alcohol Consumption History |
| 10 | Hormonal Therapy | Weight control by exercise | HbA1c | / | / | / | Body Mass Index | Number of swollen joints | Vitamin D level |